title: Access to the ophthalmic artery by retrograde approach through the posterior communicating artery for intra-arterial chemotherapy of retinoblastoma.
abstract: Intra-arterial infusion of chemotherapy into the ophthalmic artery for treatment of retinoblastoma has been realized after catheterization of the internal carotid and temporary balloon occlusion beyond the orifice of the ophthalmic artery, or more recently after superselective canulation of the ophthalmic artery by a microcatheter. The superselective catheterization of the ophthalmic artery could be cumbersome because of the implantation of the ostium on the carotid siphon or because of the tortuosity of the carotid siphon. We report our experience of using a retrograde approach through the posterior communicating artery that allows a more direct angle of access to the origin of the ophthalmic artery.
authors.affiliation: Department of Interventional Neuroradiology, Fondation Rothschild Hospital, 25 rue Manin, Paris, France.
authors.forename: Chi-Tuan
authors.initials: CT
authors.lastname: Pham
authors.forename: Raphaël
authors.initials: R
authors.lastname: Blanc
authors.forename: L
authors.initials: L
authors.lastname: Lumbroso-Le Rouic
authors.forename: Livia Lumbroso-Le
authors.initials: LL
authors.lastname: Rouic
authors.forename: Silvia
authors.initials: S
authors.lastname: Pistocchi
authors.forename: Bruno
authors.initials: B
authors.lastname: Bartolini
authors.forename: Michel
authors.initials: M
authors.lastname: Piotin
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage*; D005260:Female; D005471:Fluoroscopy; D006801:Humans; D007223:Infant; D007261:Infusions, Intra-Arterial; D008558:Melphalan / Q000008:administration & dosage*; D009880:Ophthalmic Artery; D019572:Retinal Neoplasms / Q000188:drug therapy*; D012175:Retinoblastoma / Q000188:drug therapy*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan
references.citation: Pediatr Neurosurg. 2008;44(5):388-92
references.pmid: 18703885
references.citation: Jpn J Cancer Res. 1987 Aug;78(8):858-68
references.pmid: 3115934
references.citation: AJNR Am J Neuroradiol. 2000 Feb;21(2):262-8
references.pmid: 10696006
references.citation: Radiologe. 1991 May;31(5):240-3
references.pmid: 1876695
references.citation: Clin Exp Ophthalmol. 2010 Aug;38(6):638-43
references.pmid: 20584015
references.citation: Ophthalmology. 2008 Aug;115(8):1405-10, 1410.e1-2
references.pmid: 18222001
references.citation: Arch Ophthalmol. 2010 Nov;128(11):1427-31
references.pmid: 21060044
references.citation: Arch Ophthalmol. 2011 Jun;129(6):732-7
references.pmid: 21320950
references.citation: Trans Am Acad Ophthalmol Otolaryngol. 1963 Mar-Apr;67:164-72
references.pmid: 13973597
references.citation: Ophthalmology. 2011 Oct;118(10):2081-7
references.pmid: 21715012
references.citation: Ophthalmology. 2008 Aug;115(8):1398-404, 1404.e1
references.pmid: 18342944
references.citation: Int J Clin Oncol. 2004 Apr;9(2):69-73
references.pmid: 15108036
references.citation: Orphanet J Rare Dis. 2006 Aug 25;1:31
references.pmid: 16934146
references.citation: Arch Ophthalmol. 2004 May;122(5):729-35
references.pmid: 15136321